Treatment with the diabetes drug exenatide was associated with a significant decrease in hyperglycemia in acute stroke patients, a new study shows. The research could offer clinicians an alternative ...
An ambitious, nationwide clinical trial led by UVA Health's Karen Johnston, MD, has provided doctors with long-needed insights into the importance of managing stroke patients' blood sugar after ...
Hyperglycaemia is a frequent finding in the acute phase of ischaemic stroke and constitutes an independent driver of poor neurological outcome. Elevations in blood glucose at presentation reflect both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results